Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,876.00
(
0.02%
)
Dow Jones
49,149.38
(
-0.59%
)
Brent Oil
95.01
(
4.78%
)
Bitcoin
75,576.67
(
-0.42%
)
News Focus
News Focus
Post# of 822335
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

barnstormer

Send PM Follow Ignore
Followers 21
Posts 1010
Boards Moderated 0
Alias Born 09/20/2005

barnstormer

Member Level

Re: ATLnsider post# 522877

Tuesday, 10/18/2022 7:58:08 PM

Tuesday, October 18, 2022 7:58:08 PM

Post# of 822335
ATL, I don't doubt the importance of the journal article, or the importance it would have in validating and verifying the DCVax-L trial results. I just doubt the article will have the significant impact on the NWBO share price that if would have if accepted and published in a shorter time frame once the initial phase 3 results were announced. Just my experience in that delays in expectations tend to minimize impact. Hope I'm wrong.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News